The historical rank and industry rank for Sotac Pharmaceuticals's FCF Margin % or its related term are showing as below:
NSE:SOTAC'
s FCF Margin % Range Over the Past 10 Years
Min: -34.07 Med: -22.01 Max: -1.11
Current: -16.56
During the past 6 years, the highest FCF Margin % of Sotac Pharmaceuticals was -1.11%. The lowest was -34.07%. And the median was -22.01%.
NSE:SOTAC's FCF Margin % is ranked worse than 79.9% of 955
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs NSE:SOTAC: -16.56
Sotac Pharmaceuticals FCF Margin % Related Terms
Sotac Pharmaceuticals FCF Margin % Historical Data
* Premium members only.
The historical data trend for Sotac Pharmaceuticals's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sotac Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sotac Pharmaceuticals FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sotac Pharmaceuticals's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Sotac Pharmaceuticals's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sotac Pharmaceuticals (NSE:SOTAC) has a FCF Margin % of 18.36% as of Sep. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sotac Pharmaceuticals and its competitors. According to the industry distribution chart, Sotac Pharmaceuticals ranks #763 out of 955 companies in the Drug Manufacturers industry, placing it in the top 79.9%.
Is Sotac Pharmaceuticals' FCF Margin % too high?
Sotac Pharmaceuticals' current FCF Margin % is 18.36%. The Drug Manufacturers industry median FCF Margin % is 2.51. Sotac Pharmaceuticals' value of 18.36% is 631.5% above this industry median. Based on the distribution chart, Sotac Pharmaceuticals ranks #763 out of 955 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Sotac Pharmaceuticals has a GF Score™ of 53/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sotac Pharmaceuticals' FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sotac Pharmaceuticals ranks #763 out of 955 companies for FCF Margin %. This places Sotac Pharmaceuticals in the lower half of its industry. The industry median FCF Margin % is 2.51. Sotac Pharmaceuticals' value of 18.36% is 631.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sotac Pharmaceuticals's current FCF Margin % of 18.36% is 631.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sotac Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sotac Pharmaceuticals's current FCF Margin % is 18.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sotac Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Sotac Pharmaceuticals (NSE:SOTAC) is currently considered Fairly Valued. The stock's GF Value™ is ₹110.01, compared to a current price of ₹105.00 — trading 4.6% below its estimated fair value. The current FCF Margin % is 18.36% and 631.5% above the Drug Manufacturers industry median of 2.51. Sotac Pharmaceuticals' overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Sotac Pharmaceuticals (NSE:SOTAC), the current FCF Margin % is 18.36% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sotac Pharmaceuticals (NSE:SOTAC) Overvalued in 2026?
Based on GuruFocus' analysis, Sotac Pharmaceuticals stock appears to be undervalued.
The current stock price of ₹105.00 is trading 4.6% below its estimated GF Value™ of ₹110.01.
GuruFocus considers Sotac Pharmaceuticals to be Fairly Valued.
Key valuation signals for NSE:SOTAC:
FCF Margin %: 18.36%
GF Value™: ₹110.01 vs. price of ₹105.00 (4.6% below fair value)
Industry Position: 631.5% above the Drug Manufacturers median (#763 of 955)
No single metric tells the full story. See the NSE:SOTAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sotac Pharmaceuticals Ltd operates chiefly in pharmaceutical manufacturing, serving a broad range of therapeutic segments including anti-diabetic, anti-psychotic, vitamins and minerals, anti-cold, anti-allergic, derma products, antacids, anti-ulcerants, cardiac, analgesic, anti-bacterial, anti-fungal, and more. The company manufactures tablets, capsules, syrups, and external preparations under contract manufacturing and loan licensing agreements, for domestic and international markets. Its clients include notable pharmaceutical marketers such as Cadila Pharma and Viatris. Revenue is distributed between domestic pharmaceutical product sales and international exports, supporting scalable growth across geographies.
53GF Score
Get the complete analysis for NSE:SOTAC
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SOTAC has been successfully added to your 
